N,N-Dimethylacetamide (DMAC or DMA), with the chemical formula CH?C(O)N(CH?)? and a molecular weight of 87.12 g·mol?1, is a colorless, transparent, non-protonic polar solvent. It exhibits complete miscibility with water as well as a broad range of organic solvents—including ethers, ketones, alcohols, aromatic hydrocarbons (e.g., benzene), and esters—rendering it widely applicable as a reaction medium and processing solvent in synthetic chemistry and industrial manufacturing.

Dimethylacetamide (DMAC) plays a multifaceted and strategically important role in biopharmaceutical process development, with well-documented applications across four key domains:

1. Drug Synthesis and Intermediate Preparation 

DMAC serves as a high-boiling, polar aprotic solvent and, in certain cases, as a co-catalyst in the synthesis of antibiotics—including amoxicillin and cephalosporins—as well as anti-neoplastic agents. Its use enhances reaction kinetics, improves yield, and contributes to higher product purity. In organic synthesis of pharmaceutical intermediates, DMAC is particularly advantageous for constructing hydrophobic molecular scaffolds, owing to its ability to stabilize reactive intermediates and lower activation energy barriers—thereby facilitating efficient and selective transformations.

2. Antibody–Drug Conjugate (ADC) Manufacturing 

In ADC conjugation chemistry, DMAC functions as a co-solvent to solubilize highly lipophilic cytotoxic payloads prior to coupling with monoclonal antibodies. When employed synergistically with non-ionic surfactants (e.g., polysorbates), DMAC supports micelle formation, which not only augments payload solubility but also improves coupling specificity and reaction homogeneity—critical factors for achieving consistent drug–antibody ratios (DAR) and batch-to-batch reproducibility.

3. Advanced Drug Formulation Development 

Within solid dispersion technologies—particularly co-precipitation and solvent evaporation methods—DMAC acts as an effective solvent for both active pharmaceutical ingredients (APIs) and polymeric carriers (e.g., PVP, HPMCAS). Rapid removal of DMAC under controlled conditions enables the formation of stable amorphous solid dispersions (ASDs), thereby enhancing dissolution rate, apparent solubility, and oral bioavailability of BCS Class II and IV compounds. Additionally, DMAC’s favorable film-forming capacity and compatibility with diverse excipients render it suitable for fabricating polymeric membranes, microcapsules, and other controlled-release or targeted delivery systems.

4. Biomacromolecule Processing 

In downstream processing of therapeutic proteins and nucleic acids, DMAC has demonstrated utility in solubilizing and stabilizing labile biomacromolecules during purification and extraction steps. It mitigates non-specific adsorption to chromatographic resins and reduces enzymatic or chemical degradation pathways. Furthermore, in select enzymatic syntheses (e.g., phosphorylation, ligation) and solid-phase oligonucleotide synthesis, DMAC provides a chemically inert, low-water-content environment that preserves reagent integrity and supports high-fidelity molecular assembly.

The pharmaceutical application of N,N-dimethylacetamide (DMAC) necessitates stringent control over its purity, residual moisture, and impurity profile to ensure drug quality, safety, and process robustness. To date, neither the United States Pharmacopeia (USP) nor the Chinese Pharmacopoeia (ChP) has established monographs or official quality specifications for DMAC intended for medicinal use. Consequently, the European Pharmacopoeia (Ph. Eur.) serves as the de facto regulatory benchmark for pharmaceutical-grade DMAC globally. As a globally recognized supplier of high-quality pharmaceutical raw materials and excipients, PanReac AppliChem offers Ph. Eur.-compliant DMAC characterized by ≥99.0% assay purity, rigorously controlled residual moisture and organic impurities, and trace metal content strictly aligned with ICH Q3D elemental impurities guidelines. This comprehensive quality assurance minimizes interference with critical synthetic and conjugation reactions—particularly in sensitive biopharmaceutical processes—and enhances consistency, yield, and final product quality. The material is especially well-suited for the development and manufacturing of advanced biopharmaceuticals, including antibody–drug conjugates (ADCs).

產(chǎn)品信息：

PanReac AppliChem is a European-based manufacturer of high-purity biochemical reagents and pharmaceutical raw materials with over a century of heritage. The company maintains compliance with multiple ISO quality management standards (including ISO 9001 and ISO 13485) and serves as a trusted global supplier to life science research institutions, leading contract research and manufacturing organizations (CROs/CDMOs), and major enterprises in the pharmaceutical, diagnostic, food, and cosmetic industries. As an approved long-term supplier to numerous internationally recognized cell culture medium and pharmaceutical manufacturers, PanReac AppliChem ranks among a select group of global producers capable of supplying pharmacopoeial-grade and cell-culture-grade raw materials across broad chemical portfolios. Its product portfolio encompasses cell culture–grade, pharmacopoeial-grade, biochemical-grade, and ultra-pure-grade chemicals—including amino acids, vitamins, antibiotics, salts, buffers, stabilizers, surfactants, and process-critical pharmaceutical excipients such as Tris, guanosine, adenine, sodium caprylate, DMSO, and dextran.

XMJ Scientific is the exclusive distributor of PanReac AppliChem in China，providing users with comprehensive technical support and after-sales service. If you are interested in the products, please call XMJ's customer service hotline at 400-050-4006 or visit the website m.lxhmstone.com for more information.